AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Pregabid CR 82.5 Tablet ER

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Pregabalin (82.5mg)

Overview Pregabid CR 82.5 Tablet ER

Extended-release Gabapentin CR 82.5mg tablets are prescribed to alleviate nerve pain (neuropathic pain) stemming from conditions like diabetes, shingles, spinal cord injuries, or other related ailments. This medication also treats widespread musculoskeletal pain and stiffness characteristic of fibromyalgia. Classified as an anticonvulsant, it can be used, in conjunction with other treatments, to manage specific seizure types. Furthermore, it may be prescribed for anxiety symptoms when alternative treatments prove ineffective. Gabapentin CR 82.5mg tablets can be ingested with or without food, but consistent daily timing maximizes effectiveness. Dosage and treatment length are individualized based on your response and condition. Your physician will likely initiate treatment with a low dose, gradually increasing it as needed. Therapeutic effects may not be fully realized for several weeks. Adhere strictly to your doctor's instructions, maintaining consistent use until discontinuation is advised. Missed doses can exacerbate your condition. While generally mild and self-limiting, common side effects include drowsiness, dizziness, dry mouth, blurred vision, weight gain, generalized edema, and cognitive impairment. Most side effects require no specific medical intervention. Discuss potential side effects and management strategies with your physician. Inform your doctor of pregnancy, breastfeeding, or pregnancy plans before commencing treatment. Exercise caution while operating machinery due to potential drowsiness, dizziness, and visual disturbances. Alcohol consumption should be avoided due to the risk of amplified drowsiness and dizziness.

Primary Ingredients of Pregabid CR 82.5 Tablet ER

No information provided. Please provide the text you wish me to rephrase.

Uses of Pregabid CR 82.5 Tablet ER

Managing neuropathic pain, fibromyalgia, and epilepsy/seizures.

Major Benefits of Pregabid CR 82.5 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Pregabid CR 82.5 Extended-Release Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Pregabid CR 82.5 Tablet ER:

  • Sleepiness
  • Weight gain
  • Dryness in mouth
  • Blurred vision
  • Dizziness
  • Peripheral edema

How to use Pregabid CR 82.5 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pregabid CR 82.5 Extended-Release Tablets can be administered with or without food, however, consistent timing is recommended.

How Pregabid CR 82.5 Tablet ER works:

Extended-release pregabalin 82.5 mg tablets are used to control seizures in epilepsy. Their mechanism involves dampening excessive electrical discharges within the brain, thereby preventing seizure onset. This medication also provides relief from neuropathic pain by disrupting the transmission of pain signals along damaged nerves and to the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Pregabid CR 82.5 extended-release tablets and alcohol can result in heightened somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release pregabalin 82.5 mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release pregabalin 82.5 mg tablets are likely unsuitable for breastfeeding mothers. Available data from human studies indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Extended-release pregabalin 82.5 mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Extended-release pregabalin 82.5 mg tablets require careful administration in individuals with impaired renal function. Dosage modification of extended-release pregabalin 82.5 mg tablets may be necessary. Physician consultation is recommended.

LiverLiverSAFE IF PRESCRIBED

Patients with hepatic impairment can safely take Pregabid CR 82.5 Tablet ER without requiring a dosage modification.

What if you forget to take Pregabid CR 82.5 Tablet ER :

Should you forget a Pregabid CR 82.5 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Pregabid CR 82.5 Tablet ER

LabelValue
Chemical Classification GABA-based Cyclic Compounds
Developing Habits No.
Treatment Category Neuroscience (CNS)

FAQs on Pregabid CR 82.5 Tablet ER

Pregabalin CR 82.5 mg Extended-Release tablets are anticonvulsants used to manage seizures and neuropathic pain (nerve pain) stemming from conditions like diabetes, shingles, or injury. They're also prescribed for fibromyalgia, a chronic condition causing pain, fatigue, muscle stiffness, and sleep disturbances. In certain cases, this medication may be used to treat anxiety.
Pregabalin CR 82.5 mg extended-release tablets act differently depending on the condition. In epilepsy, it reduces excessive brain electrical activity to prevent seizures. For chronic pain, it interrupts pain signals between the spine and brain.
While complete pain relief from Pregabid CR 82.5 Tablet ER may take several weeks, many users report noticeable improvement within a week.
The length of Pregabalin CR 82.5 mg Extended-Release Tablet treatment varies depending on your condition. For epilepsy, long-term use (potentially years) may be necessary if the medication proves effective. In cases of neuropathic pain or fibromyalgia, continued use for several months after symptom improvement helps prevent relapse. Always consult your doctor before discontinuing this medication.
Continue taking Pregabid CR 82.5 Tablet ER even if you feel well. Abruptly stopping this medication, especially if prescribed for epilepsy, can trigger uncontrollable seizures. Sudden cessation may also cause withdrawal symptoms such as anxiety, insomnia, nausea, pain, and sweating. These symptoms can be avoided by gradually reducing your dosage.
Misuse of Pregabid CR 82.5 Tablet ER, including exceeding prescribed doses or prolonged use, significantly increases the risk of addiction. Individuals with a history of substance abuse should avoid this medication. If you suspect Pregabid CR 82.5 Tablet ER dependence, contact your doctor promptly.
Combining Pregabalin CR 82.5mg Extended-Release tablets and diazepam is possible, however, the risk of heightened side effects exists due to their shared mechanism of central nervous system depression.
Pregabalin CR 82.5 mg Extended-Release tablets are anticonvulsants used to manage seizures and neuropathic pain from conditions like diabetes, shingles, or injury. They also treat fibromyalgia, a chronic condition causing pain, fatigue, muscle stiffness, tenderness, and sleep disturbances. In certain cases, your doctor might prescribe them for anxiety.
Pregabalin CR 82.5 mg extended-release tablets act differently depending on the condition. In epilepsy, it reduces excessive brain electrical activity to prevent seizures. For chronic pain, it interrupts pain signals between the spine and brain.
While complete benefits from Pregabid CR 82.5 Tablet ER may take several weeks to appear, some users report pain relief within a week.
Treatment duration for Pregabalin CR 82.5mg Extended-Release tablets varies depending on your condition. For epilepsy, long-term use (years) may be necessary if the medication is effective. For neuropathic pain or fibromyalgia, continued use for several months after symptom improvement helps prevent recurrence. Always consult your doctor before discontinuing this medication.
Continue taking Pregabid CR 82.5 Tablet ER as prescribed, even if you feel well. Abruptly stopping this medication, especially if used for epilepsy, can trigger uncontrollable seizures. Sudden cessation may also cause withdrawal symptoms such as anxiety, insomnia, nausea, pain, and sweating. These symptoms can be minimized by gradually reducing your dose under medical supervision.
Misuse of Pregabid CR 82.5 Tablet ER, including exceeding prescribed doses or prolonged use, significantly increases the risk of addiction. Individuals with a history of substance abuse should avoid this medication. If you suspect you're developing a physical dependence on Pregabid CR 82.5 Tablet ER, contact your doctor promptly.
Yes, Pregabalin CR 82.5 mg extended-release tablets and diazepam can be used concurrently, but this combination may increase the risk of side effects due to their shared mechanism of central nervous system depression.
Pregabalin CR 82.5mg extended-release tablets can lead to weight gain due to increased appetite. Maintaining a healthy weight may involve regular exercise and a balanced, lower-calorie diet. A registered dietitian can provide personalized guidance if needed.
Pregabid CR 82.5 Tablet E...
181
MRP 210
13% off